Opes Wealth Management LLC Gilead Sciences, Inc. Transaction History

Opes Wealth Management LLC

$514 Million
Q3 2024

A detailed history of Opes Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Opes Wealth Management LLC holds 157,089 shares of GILD stock, worth $14.8 Million. This represents 2.56% of its overall portfolio holdings.

Number of Shares

157,089

Previous 158,751 1.05%

Holding current value

$14.8 Million

Previous $10.9 Million 20.9%

% of portfolio

2.56%

Previous 2.29%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$66.59 - $83.99 $110,672 - $139,591	-1,662 Reduced 1.05%	157,089 $13.2 Million
Q2 2024 Aug 05, 2024	BUY	$63.15 - $72.88 $15,408 - $17,782	244 Added 0.15%	158,751 $10.9 Million
Q1 2024 May 02, 2024	BUY	$71.58 - $87.29 $38,008 - $46,350	531 Added 0.34%	158,507 $11.6 Million
Q4 2023 Jan 31, 2024	SELL	$73.27 - $83.09 $20,295 - $23,015	-277 Reduced 0.18%	157,976 $12.8 Million
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $49,983 - $54,532	676 Added 0.43%	158,253 $11.9 Million
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $19,838 - $22,628	261 Added 0.17%	157,577 $12.1 Million
Q1 2023 May 01, 2023	BUY	$77.31 - $88.08 $83,340 - $94,950	1,078 Added 0.69%	157,316 $13.1 Million
Q4 2022 Jan 30, 2023	BUY	$62.32 - $89.47 $641,272 - $920,646	10,290 Added 7.05%	156,238 $13.4 Million
Q3 2022 Oct 31, 2022	BUY	$59.54 - $68.01 $79,664 - $90,997	1,338 Added 0.93%	145,948 $9 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $103,376 - $116,432	1,791 Added 1.25%	144,610 $8.94 Million
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $486,599 - $552,300	-7,500 Reduced 4.99%	142,819 $10.4 Million
Q3 2021 Oct 29, 2021	BUY	$67.69 - $73.03 $126,783 - $136,785	1,873 Added 1.26%	150,319 $10.5 Million
Q2 2021 Aug 03, 2021	BUY	$63.47 - $69.35 $3.22 Million - $3.52 Million	50,700 Added 51.87%	148,446 $10.2 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $6,210 - $7,808	100 Added 0.1%	97,746 $6.18 Million
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $7.06 Million - $8.2 Million	97,646 New	97,646 $7.23 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opes Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opes Wealth Management LLC with notifications on news.

Account

Opes Wealth Management LLC Gilead Sciences, Inc. Transaction History